New Japanese Vaccine Promises to Double Cats’ Lifespan (Eric Han / Unsplash)
Japanese scientists are developing an injectable vaccine called the ‘AIM vaccine‘ that has the potential to double the lifespan of some cats by combating chronic kidney disease, which is common in elderly felines.
This discovery comes after identifying a protein called AIM, which plays a crucial role in the feline immune system, especially in protecting the kidneys from disease.
Clinical trials have shown promising results, offering hope for extending the lifespan and improving the quality of life for affected cats.
Lead researcher Toru Miyazaki found a way to harness the AIM protein to help cats with advanced kidney disease. Miyazaki received significant financial support, boosting his research to make the treatment widely accessible.
If all goes well, the AIM vaccine could be commercially available by 2025, with future plans to apply the same technology to treat kidney and liver diseases in humans.
This innovation has the potential to transform the lives of millions of cats worldwide and also highlights how scientific advances in veterinary medicine can eventually benefit human health.
Click here to check out the research
Source: Cole and Marmalade
This content was created with the help of AI and reviewed by the editorial team.
